Table 6 Characterization of IMQ NEs
Formulation | Parameters | PDI | |||
|---|---|---|---|---|---|
Drug content (%) | % Entrapment efficiency | pH | Viscosity (Poise) | ||
F1 | 102.89 ± 1.06 | 97.59 ± 0.24 | 4.77 ± 0.06 | 4.06 ± 0.07 | 0.14 ± 0.01 |
F2 | 97.64 ± 2.36 | 91.11 ± 0.48 | 4.60 ± 0.10 | 1.32 ± 0.02 | 0.43 ± 0.01 |
F3 | 95.25 ± 1.80 | 90.63 ± 0.22 | 4.17 ± 0.12 | 1.11 ± 0.00 | 0.39 ± 0.09 |
F4 | 96.42 ± 1.65 | 92.81 ± 0.15 | 4.33 ± 0.06 | 1.76 ± 0.08 | 0.29 ± 0.11 |
F5 | 99.15 ± 0.98 | 98.03 ± 0.04 | 4.23 ± 0.06 | 6.46 ± 0.03 | 0.28 ± 0.05 |
F6 | 97.90 ± 1.48 | 93.21 ± 0.21 | 4.30 ± 0.10 | 4.21 ± 0.02 | 0.37 ± 0.06 |
F7 | 98.05 ± 1.48 | 95.54 ± 0.16 | 4.60 ± 0.10 | 2.92 ± 0.02 | 0.37 ± 0.05 |
F8 | 97.47 ± 2.13 | 94.01 ± 0.21 | 4.57 ± 0.06 | 1.22 ± 0.01 | 0.45 ± 0.06 |
F9 | 96.80 ± 1.92 | 93.01 ± 0.21 | 4.40 ± 0.10 | 5.30 ± 0.00 | 0.31 ± 0.01 |